## CPAY: Corpay, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.90 indicates fundamental undervaluation. Quality metrics strong (ROE 29%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-4.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($294.23)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $380 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | up | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- JPMORGAN CHASE & CO: 12.7% (+93.8%)
- Vanguard Group Inc: 11.7% (+0.7%)
- Blackrock Inc.: 9.0% (+0.3%)
- Orbis Allan Gray Ltd: 5.9% (+7.1%)
- Price (T.Rowe) Assoc: 5.5% (-21.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.7% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 12.5x attractive for 17% earnings growth. Quality metrics strong (ROE 29%, margin 24%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.9B |
| Beta | 0.85 |
| 52W Range | $252.84 - $400.81 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 12.5 |
| Current P/E | 14.6 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.1% to 0.5% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >4.0% for momentum thesis). MRS_5 (-1.6%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 58. OFD pattern: -STL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.46% (CS: 60) | Neutral |
| RSI_14 | 57.7 | Neutral |
| MACD Histogram | -0.28 | Bearish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 0.985x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $309.55
- **Stop Loss:** $294.23 (4.9% risk)
- **Target:** $340.19 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 78
- **Position Value:** $24,144.90
- **Portfolio %:** 24.14%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-04 (Est: $5.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.64 | $5.70 | +1.0% |
| 2025Q2 | $5.12 | $5.13 | +0.1% |
| 2025Q1 | $4.51 | $4.51 | -0.1% |
| 2024Q4 | $5.35 | $5.36 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*